Metraipolis › archive › dc_7eb45505939d

Efficacy and safety of combination immunotherapy and targeted therapy as second-line and subsequent treatments for advanced biliary tract cancer: A systematic… — Europe PMC PMID:42332460

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42332460
DOI
10.1097/md.0000000000049290
License (as archived)
solo-consultazione
Archived
2026-11-01T01:33:46.295Z
SHA-256 of the archived text
9f25c3b620af14cdb6617100093a53c68357c7bfa386591acc91ccef7d73e83e
Stable URL of this page
https://metraipolis.com/documento/dc_7eb45505939d

How to cite

Efficacy and safety of combination immunotherapy and targeted therapy as second-line and subsequent treatments for advanced biliary tract cancer: A systematic… — Europe PMC PMID:42332460 — Europe PMC (en), https://europepmc.org/article/MED/42332460 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7eb45505939d (Metraipolis archive dc_7eb45505939d, sha256 9f25c3b620af14cdb6617100093a53c68357c7bfa386591acc91ccef7d73e83e)
BibTeX
@misc{dc7eb45505939d,
  title = {Efficacy and safety of combination immunotherapy and targeted therapy as second-line and subsequent treatments for advanced biliary tract cancer: A systematic… — Europe PMC PMID:42332460},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42332460},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7eb45505939d; sha256 9f25c3b620af14cdb6617100093a53c68357c7bfa386591acc91ccef7d73e83e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42332460. Agents can read the archived copy with the MCP tool read_document.